Indian markets are likely to see a cautious start today, with Gift Nifty indicating a subdued opening amid mixed global cues and ongoing geopolitical uncertainties. Investor sentiment remains sensitive to global developments, even as stock-specific triggers continue to drive action across sectors.
A list of all stocks in news today:
DCX Systems: Secured a major ₹563.45 crore order for airborne maritime patrol radar, boosting order book visibility.
Ceigall India: Subsidiary emerged as L1 bidder for a ₹603 crore NHAI project in Punjab, strengthening infrastructure pipeline.
Railtel: Bagged a ₹160 crore order from Prasar Bharti, supporting near-term revenue visibility.
Eris Lifesciences: Launched generic semaglutide under brand ‘Sundae’ in India, entering high-growth diabetes segment.
Wipro: Introduced AI-DC solution to accelerate enterprise AI adoption, enhancing digital capabilities.
Tulsyan NEC: Secured 60 MW round-the-clock power supply order from TNPDCL, improving business outlook.
PVR Inox: Opened a 4-screen multiplex in Agra, expanding its footprint.
Tata Power: Gujarat Cabinet approved supplementary PPA for Mundra plant, aiding long-term supply visibility.
Devyani International: Board approved investment of Thai Baht 1.21 billion in Restaurants Development Co., supporting expansion plans.
Veerhealth Care: Won ₹5.50 crore order for personal care products, indicating steady demand.
Crompton Greaves: Launched new product ‘Energion Elevate’, expanding product portfolio.
Kiri Industries: Announced ₹8,100 crore expansion into copper and fertilisers, marking a major diversification move.
HFCL: Board to consider fund raise via preferential issue of warrants on March 25.
Simplex Castings: Secured ₹41.38 crore orders from industrial players.
Patel Engineering: Received ₹230.7 crore LoA from Bhutan-based hydropower project.
Zydus Life: Launched semaglutide injection in reusable multi-dose pen device in India.
Glenmark Pharmaceuticals: Introduced GLIPIQ® semaglutide, targeting affordability in GLP-1 therapy.
Sun Pharma: Rolled out semaglutide injections under new brands, intensifying competition.
Dr. Reddy’s Laboratories: Launched India’s first DCGI-approved semaglutide injection ‘Obeda’.
Alkem Laboratories: Received DCGI nod for semaglutide injection manufacturing and marketing.
Torrent Pharmaceuticals: Launched both oral and injectable semaglutide formulations.
NBFCs: Government approved ₹20,000 crore credit guarantee scheme for microfinance institutions, improving sector sentiment.
Vindhya Telelinks: Approved merger of Birla Cable with the company.
Kirloskar Ferrous: Resumed operations of moulding line at Solapur plant.
Jindal Poly Films: Monet Securities bought 8.45 lakh shares at ₹1,028 per share.
Transworld Shipping Lines: Signed agreement to sell vessel for $11.90 million.
RITES: Received ₹106 crore LoI from RDSO.
IRB Infrastructure: Promoter entity acquired 24 lakh shares, indicating confidence.
Omaxe: Subsidiaries secured RERA approvals for projects in Punjab and Uttar Pradesh.
Ashok Leyland: Approved investment of up to GBP 30 million in UK subsidiary Optare Plc.
Torrent Power: Subsidiary acquired 100% stake in Onix-One Enersol for green energy expansion.
HDFC Bank: Reports suggest internal developments amid AT1 probe, with management changes under discussion.
Divi’s Laboratories: Received draft tax assessment order with ₹570.51 crore proposed additions.
IDBI Bank: Government may consider OFS to increase public float.
Infosys: Launched AI-powered race centre in collaboration with Formula E.
Elgi Equipments: Flagged LPG supply constraints, posing potential risk to manufacturing output.
SBI: Received ₹6,337 crore tax demand from the Income Tax Department for AY24, which could weigh on sentiment.